SGLT2 Inhibitors Market to Attain USD 34.6 Billion by 2036, China...

a adăugat un sunet Alte

2026-10-21 08:41:41 -

SGLT2 Inhibitors Market to Attain USD 34.6 Billion by 2036, China Leads at 8.4%, Germany Follows at 7.1%

The SGLT2 inhibitors market is forecast to expand from USD 19 billion in 2026 to USD 34.6 billion by 2036, registering a 6.2% CAGR over the forecast period. Fact.MR attributes this expansion to the increasing prevalence of type 2 diabetes, growing demand for effective blood glucose management, and wider use of SGLT2 inhibitors in treating heart failure and chronic kidney disease. The market was...

0 Commentarii 0 Distribuiri 9 Views 0 previzualizare